These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1117759)

  • 21. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
    Yoshida T; McCormick WC; Swell L; Vlahcevic ZR
    Gastroenterology; 1975 Feb; 68(2):335-41. PubMed ID: 1116679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of chenodeoxycholic acid in the nonhuman primate.
    Morrissey KP; McSherry CK; Swarm RL; Nieman WH; Deitrick JE
    Surgery; 1975 Jun; 77(6):851-60. PubMed ID: 1145445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts.
    Ceryak S; Bouscarel B; Malavolti M; Fromm H
    Hepatology; 1998 Feb; 27(2):546-56. PubMed ID: 9462656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of biliary cholesterol, phospholipids and bile acid compositions and the development of cholesterol cholelithiasis in mice].
    Yamahara J; Chisaka T; Sawada T; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):171-80. PubMed ID: 6662416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of prosthetic gallstones on total bile acid pool size in dogs.
    Thurston OG; McDougall RM; Walker K
    Surg Gynecol Obstet; 1978 Jun; 146(6):911-3. PubMed ID: 653567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of ursodeoxycholic acid in man.
    Fedorowski T; Salen G; Calallilo A; Tint GS; Mosbach EH; Hall JC
    Gastroenterology; 1977 Nov; 73(5):1131-7. PubMed ID: 908492
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
    Thistle JL; Hofmann AF
    N Engl J Med; 1973 Sep; 289(13):655-9. PubMed ID: 4580472
    [No Abstract]   [Full Text] [Related]  

  • 28. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK; Salen G; Abroon J
    Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of deoxycholic, chenodeoxycholic, and cholic acids on intestinal absorption of cholesterol in humans.
    Sama C; LaRusso NF
    Mayo Clin Proc; 1982 Jan; 57(1):44-50. PubMed ID: 7033682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial serum bile acids in cholestasis of pregnancy.
    Laatikainen T
    Ann Clin Res; 1978 Dec; 10(6):307-12. PubMed ID: 742829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects.
    LaRusso NF; Szczepanik PA; Hofmann AF
    Gastroenterology; 1977 Jan; 72(1):132-40. PubMed ID: 318580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile salts in health and disease.
    Papp JP
    Mich Med; 1972 Oct; 71(30):865-9. PubMed ID: 4567570
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man.
    Einarsson K; Grundy SM
    J Lipid Res; 1980 Jan; 21(1):23-34. PubMed ID: 7354252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-sulfated bile acids in rat liver cells. Studies on the toxicity of chenedeoxycholic acid].
    Kurtz W; Janka P; Swoboda L; Leuschner U
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():496-9. PubMed ID: 612015
    [No Abstract]   [Full Text] [Related]  

  • 39. Marked increase in serum levels of liver enzymes in patients receiving chenic acid and phenobarbital for gallstone dissolution.
    Menghini G; Pallotta B
    Digestion; 1976; 14(2):163-9. PubMed ID: 950079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stigmasterol as internal standard for simultaneous quantitation of biliary cholesterol and bile acids by gas-liquid chromatography.
    Subbiah MT
    Clin Chim Acta; 1973 Sep; 48(1):19-21. PubMed ID: 4746726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.